Document:

Exhibit 10.4

COVIDIEN

UNI-PATCH DIVISION

 

FIRST AMENDMENT

TO

SUPPLY AGREEMENT

 

This First Amendment, entered into as of the 26th day of February, 2008 (the "First Amendment"), is by and between Tyco Healthcare Group LP (d/b/a Covidien), a Delaware limited partnership, acting through its Uni-Patch Division, having a place of business at 1313 West Grant Boulevard, Wabasha, Minnesota 55981 (hereinafter referred to as "Supplier"), and Uroplasty, Inc., a Minnesota corporation, having a place of business at 5420 Fern Rd., Minnetonka, MN, 55343 (hereinafter referred to as "Purchaser").

 

WHEREAS, Supplier and Purchaser are both parties to a Supply Agreement, dated December 6th', 2007 (the "Supply Agreement"); and

 

WHEREAS, the parties now wish to amend the Supply Agreement as contained in this First Amendment.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained, the parties mutually agree as follows:

 

1.             Section 1.1 of the Supply Agreement shall be deleted and replaced with the following:

 

1.1          "Contract Year" shall mean, with respect to the first Contract Year, that time period that begins with the Effective Date of the Agreement and concludes on April 30, 2009, and, with respect to the second Contract Year, that time period that begins on May 1, 2009 and concludes on April 30, 2010.

 

2.             Section 2 of the Supply Agreement shall be deleted and replaced with the following:

 

This Agreement shall commence upon the Effective Date and shall continue in effect for until April 30, 2010 ("Term"), unless earlier terminated pursuant to Section 8.

 

All other terms of the Supply Agreement not specifically amended herein shall remain unchanged.

 

Exhibit 10.4

 

IN WITNESS WHEREOF, the parties have caused this First Amendment to be executed by their respective duly authorized representatives as of the date first written above.

 

	
Supplier:

	
Purchaser:

	
TYCO HEALTHCARE GROUP LP,

	
UROPLASTY, INC.

	
acting through its Uni-Patch Division

	
 

 

	
By:

	
/s/ Tony Mulone

	
By:

	
/s/ Marc M. Herregraven

	
Name:  

	
Tony Mulone

	
Name:  

	
Marc M. Herregraven

	
Title:

	
VP/GM – OEM Division

	
Title:

	
VP of ManufacturingExhibit 10.5

 

COVIDIEN

UNI-PATCH DIVISION

 

SECOND AMENDMENT

TO

SUPPLY AGREEMENT

 

This Second Amendment, entered into as of the 24th day of March, 2010 (the "Second Amendment"), is by and between Tyco Healthcare Group LP (d/b/a Covidien), a Delaware limited partnership, acting through its Uni-Patch Division, having a place of business at 1313 West Grant Boulevard, Wabasha, Minnesota 55981 (hereinafter referred to as "Supplier"), and Uroplasty, Inc., a Minnesota corporation, having a place of business at 5420 Felt1 Rd., Minnetonka, MN, 55343 (hereinafter referred to as "Purchaser").

 

WHEREAS, Supplier and Purchaser are both parties to a Supply Agreement, dated December 6th, 2007, which was amended by the First Amendment to Supply Agreement, dated February 26th, 2008 (the "Supply Agreement"); and

 

WHEREAS, the parties now wish to amend the Supply Agreement as contained in this Second Amendment.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained, the parties mutually agree as follows:

 

1.               Section 1.1 of the Supply Agreement shall be deleted and replaced with the following:

 

1.1          "Contract Year" shall mean that time period that begins on May 1, 2010 and concludes on April 30, 2011.

 

2.               Section 2 of the Supply Agreement shall be deleted and replaced with the following:

 

This Agreement shall commence upon the Effective Date and shall continue in effect for until April 30, 2011 ("Term"), unless earlier terminated pursuant to Section 8.

 

3.               Section 4.5 of the Agreement is hereby deleted.

 

4.               Exhibit A of the Supply Agreement shall be deleted and replaced with the new Exhibit A attached hereto.

 

All other terms of the Supply Agreement not specifically amended herein shall remain unchanged.

 

 

Exhibit 10.5

 

  IN WITNESS WHEREOF, the parties have caused this First Amendment to be executed by their respective duly authorized representatives as of the date first written above.

	
Supplier:

	
Purchaser:

	
TYCO HEALTHCARE GROUP LP,

	
UROPLASTY, INC.

	
acting through its Uni-Patch Division

	 

 

	
By:

	
/s/ Tony Mulone

	
By:

	
/s/ Marc M. Herregraven

	
Name:  

	
Tony Mulone

	
Name:  

	
Marc M. Herregraven

	
Title:

	
VP/GM – OEM Division

	
Title:

	
VP of Manufacturing

 

Exhibit 10.5

 

EXHIBIT A

 

Products and Pricing

 

	 	
Product

	 	
Description

	 	
Price

	 	
Code

	 	 	 	 
	 	
UPC250-12

	 	
UPC Stimulation Lead Sets

	 	
$*

Lead Time for Shipments from Date of Purchase Order (following initial order): 8 weeks

 

Delivery Location:

Minnetonka, MN

 

		*	
Indicates that confidential information has been omitted and filed separately with the Securities and Exchange Commission.Exhibit 10.6

 

THIRD AMENDMENT TO SUPPLY AGREEMENT

 

This THIRD AMENDMENT TO SUPPLY AGREEMENT (this "Amendment') is entered into as of the 30TH day of April, 2011 (the "Amendment Effective Date"), by and between Uroplasty, Inc. ("Purchaser"), and Tyco Healthcare Group LP (d/b/a Covidien) acting through its Uni-Patch Division ("Supplier).

 

Supplier and Purchaser are both parties to a Supply Agreement, dated December 6th, 2007, which was amended by the First Amendment to Supply Agreement, dated February 26th, 2008 and the Second Amendment to Supply Agreement, dated March 24, 2010 (the "Agreement'). The parties wish to amend the Agreement in accordance with the terms and conditions set forth herein. Any capitalized term used in this Amendment without definition will have the meaning ascribed to it in the Agreement.

 

NOW, THEREFORE, the parties hereto agree as follows:

 

Section 1.          Contract Year. Section 1.1 of the Agreement is hereby deleted and replaced with the following:

 

1.1          "Contract Year shall mean each consecutive twelve-month period commencing as of May 1 and ending as of the immediately succeeding April 30.

 

Section 2.          Term. Section 2 of the Supply Agreement is hereby deleted and replaced with the following:

 

This Agreement shall commence upon the Effective Date and shall continue in effect until April 30, 2014 ("Term"), unless earlier terminated pursuant to Section 8.

 

Section 3.          Products and Pricing. Exhibit A of the Agreement is hereby amended by deleting it in its entirety and replacing it with the Exhibit A attached to this Amendment.

 

Section 4.          Ratification. Except as specifically provided in this Amendment, the terms and provisions of the Agreement will be and remain unaltered and in full force and effect. For avoidance of doubt, the parties expressly agree and confirm that the Agreement has continued, and does continue, in full force and effect and without lapse or termination notwithstanding whether the actual date of execution hereof is after the Amendment Effective Date.

 

THE PARTIES HAVE CAUSED this Amendment to be duly executed as of the Amendment Effective Date.

 

	
UROPLASTY, INC.

	
TYCO HEALTHCARE GROUP LP (D/B/A

COVIDIEN acting through its Uni-Patch Division

 

	
By:

	
/s/ Tony Mulone

	
By:

	
/s/ Marc M. Herregraven

	
Name:  

	
Tony Mulone

	
Name:  

	
Marc M. Herregraven

	
Title:

	
VP/GM – OEM Division

	
Title:

	
VP of Manufacturing

 

EXHIBIT A

Products and Pricing

 

	 	
Product Code

	 	
Description

	 	
Price

	 	
UPC250-12

	 	
UPC Stimulation Lead Sets

	 	
$*

 

Lead Time for Shipments from Date of Purchase Order: 8 weeks

 

Delivery Location: Minnetonka, MN

		*	
Indicates that confidential information has been omitted and filed separately with the Securities and Exchange Commission.Exhibit 10.7

 

FOURTH AMENDMENT TO SUPPLY AGREEMENT

This FOURTH AMENDMENT TO SUPPLY AGREEMENT (this “Amendment”) is entered into as of March 31, 2014 (the “Amendment Effective Date”), by and between Uroplasty, Inc. (“Purchaser”), and Covidien Sales LLC (assignee in interest of Covidien LP, f/k/a Tyco Healthcare Group LP) (“Supplier”).

Supplier and Purchaser are both parties to a Supply Agreement, dated December 6th, 2007, as amended (the “Agreement”).  The parties wish to amend the Agreement in accordance with the terms and conditions set forth herein.  Any capitalized term used in this Amendment without definition will have the meaning ascribed to it in the Agreement.

NOW, THEREFORE, the parties hereto agree as follows:

Section 1.          Term.  Effective as of the Amendment Effective Date, Section 2 of the Supply Agreement is hereby deleted and replaced with the following:

This Agreement shall commence upon the Effective Date and shall continue in effect until April 30, 2017 (“Term”), unless earlier terminated pursuant to Section 8.

Section 2.          Shipping. Effective as of May 1, 2014, Section 4.3 of the Agreement is hereby amended by deleting it in its entirety and replacing it with the following:

The Products sold to Purchaser shall be shipped at Supplier’s cost (for standard delivery) to Purchaser’s Minnetonka, MN facility via a carrier of Supplier’s choice.

Section 3.          Pricing.  Effective as of May 1, 2014, Exhibit A of the Agreement is hereby deleted in its entirety and replaced with the Exhibit A attached hereto.

Section 4.          Rebate.  Effective as of May 1, 2014, Section 4.5 of the Agreement is hereby deleted in its entirety and replaced with the following:

4.5          At least thirty (30) days prior to the beginning of each Contract Year, Purchaser and Supplier will mutually agree upon an estimated annual quantity of Product purchases for such Contract Year based on historical purchases and Purchaser’s estimated annual production needs (the “Annual Quantity”).  Pricing for such Contract Year will be based on the price allocated for such estimated Annual Quantity as set forth in Exhibit A (the “Estimated Price”).  At the end of such Contract Year, Supplier will calculate Purchaser’s actual Annual Quantity for the Contract Year, and pricing for all Product purchases during such Contract Year will be adjusted to match the price allocated for such actual Annual Quantity as set forth in Exhibit A (the “Actual Price”). Within sixty (60) days after the end of such Contract Year, the parties will conduct a true-up based on the difference between the Actual Price that should have been paid for all Product units, and the Estimated Price actually paid for all Product units, and Supplier will either pay a rebate to Purchaser, or Purchaser will pay a chargeback to Supplier, as applicable, to make the other party whole for such pricing differential.

Section 5.          Ratification.  Except as specifically provided in this Amendment, the terms and provisions of the Agreement will be and remain unaltered and in full force and effect.  For avoidance of doubt, the parties expressly agree and confirm that the Agreement has continued, and does continue, in full force and effect and without lapse or termination notwithstanding whether the actual date of execution hereof is after the Amendment Effective Date.

THE PARTIES HAVE CAUSED this Amendment to be duly executed as of the Amendment Effective Date.

	
UROPLASTY, INC.

	 	
COVIDIEN SALES LLC

acting through its Uni-Patch Division 

	 	 	 
	
Signature: /s/ Marc M. Herregraven

	 	
Signature: /s/ Tony Mulone

	
Name: Marc M. Herregraven

	 	
Name: Tony Mulone

	
Title: VP of Manufacturing

	 	
Title: Vice President and General Manager, CPS

 

Exhibit A

Products and Pricing

	 	
Product Code

(Uroplasty P/N)

		
Description

	 	
Annual Volume

	 	
Price*

	 	
UPC250-12

	 	
MK78100 UPC Stimulation Lead Sets

	 	
**

	 	
$**

	 	 	 	 	 	
**

	 	
$**

	 	 	 	 	 	
**

	 	
$**

	 	 	 	 	 	
**

	 	
$**

*Pricing to be established at the beginning of each Contract Year with a true-up at the end of each Contract Year as further set forth in Section 4.5.

Estimated Price for the Contract Year starting May 1, 2014 will be at the ** Annual Volume level ($**).

Lead Time for shipments from date of Supplier’s receipt of Purchase Order:  8 weeks

Forecasts to be placed by Purchaser pursuant to Section 3.4.

To help mitigate against potential back-order situations, Supplier will carry 3.5 months’ worth of leadwire component inventory (SKU W00101) based upon Purchaser’s forecasts.

		**	
Indicates that confidential information has been omitted and filed separately with the Securities and Exchange Commission.

 

 

-2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}]]